P2RX7 and epilepsy: In conclusion, while a possible benefit for P2X7 antagonism during acute seizures and epileptogenesis remains controversial, recent research has shown the potential of P2X7 antagonists for the treatment of epilepsy, thereby providing a much needed new target with a new mechanism of action distinct from currently used AEDs.